Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035071 | SCV000058711 | benign | not specified | 2020-07-27 | criteria provided, single submitter | clinical testing | The p.Thr1493Thr variant in APC is classified as benign because it has been identified in 82% (16364/19946) of East Asian chromosomes, including 6724 homozygotes, by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Eurofins Ntd Llc |
RCV000035071 | SCV000109824 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000162372 | SCV000212682 | benign | Hereditary cancer-predisposing syndrome | 2014-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000035071 | SCV000301595 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000383485 | SCV000452013 | benign | APC-Associated Polyposis Disorders | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV001636617 | SCV000602515 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003315552 | SCV000647520 | benign | Familial adenomatous polyposis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162372 | SCV000681669 | benign | Hereditary cancer-predisposing syndrome | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001636617 | SCV001847829 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496525 | SCV002808339 | benign | Desmoid disease, hereditary; Familial adenomatous polyposis 1; Hepatocellular carcinoma; Gastric cancer; Colorectal cancer; Gastric adenocarcinoma and proximal polyposis of the stomach | 2022-05-24 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315552 | SCV004017438 | benign | Familial adenomatous polyposis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Systems Biology Platform Zhejiang California International Nano |
RCV000074234 | SCV000105827 | cancer | Familial colorectal cancer | no assertion criteria provided | not provided | Converted during submission to other. | |
Mayo Clinic Laboratories, |
RCV000035071 | SCV000256997 | benign | not specified | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV001353469 | SCV000591174 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.4479G>A, p.Thr1493Thr variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction, and is listed in dbSNP (rs_id: rs41115) as a common polymorphism with a global minor allele frequency of 0.338. It has not been previously identified by our laboratory, but has been reported in the literature in 72/2142 (frequency of 0.033) proband chromosomes from individuals with familiar adenamatous polyposis, colorectal carcinoma, papillary thyroid carcinoma and sporadic ependymoma. It has also been identified in 54/2322 (frequency of 0.023) control chromosomes, increasing the likelihood that the variant has no clinical significance (Rocco_2006, Azzopardi_2008_18199528, Chao_2006_16569251, Curia_2012_21995949, Jasperson_2010_20420945, Kamory_2008_18369740, Onilude_2006_16843107, Schwab_2008_18026870, Subramaniam_2007_18024325, Teijeiro_2009_19095577). In summary, based on the above information, this variant is classified as benign. | |
Diagnostic Laboratory, |
RCV000035071 | SCV001742783 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000035071 | SCV001922241 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035071 | SCV001953579 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000035071 | SCV001971880 | benign | not specified | no assertion criteria provided | clinical testing | ||
Institute for Biomarker Research, |
RCV000162372 | SCV002050302 | benign | Hereditary cancer-predisposing syndrome | 2021-12-21 | no assertion criteria provided | clinical testing |